Commission Implementing Regulation (EU) 2018/1266 of 20 September 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-decanol, 6-benzyladenine, aluminium sulfate, azadirachtin, bupirimate, carboxin, clethodim, cycloxydim, dazomet, diclofop, dithianon, dodine, fenazaquin, fluometuron, flutriafol, hexythiazox, hymexazol, indolylbutyric acid, isoxaben, lime sulphur, metaldehyde, paclobutrazol, pencycuron, sintofen, tau-fluvalinate and tebufenozide
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD) Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Joint committee decision (JCD)
120/2019 In force in the EEA
Yes Legal documents
Commission Implementing Regulation (EU) 2018/1266 of 20 September 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 1-decanol, 6-benzyladenine, aluminium sulfate, azadirachtin, bupirimate, carboxin, clethodim, cycloxydim, dazomet, diclofop, dithianon, dodine, fenazaquin, fluometuron, flutriafol, hexythiazox, hymexazol, indolylbutyric acid, isoxaben, lime sulphur, metaldehyde, paclobutrazol, pencycuron, sintofen, tau-fluvalinate and tebufenozide
Framkvæmdarreglugerð framkvæmdastjórnarinnar (ESB) 2018/1266 frá 20. september 2018 um breytingu á framkvæmdarreglugerð (ESB) nr. 540/2011 að því er varðar framlengingu á samþykkistímabilum fyrir virku efnin 1-dekanól, 6-bensýladenín, álsúlfat, asadíraktín, búpírímat, karboxín, kletódím, sýkloxýdím, dasómet, díklófóp, díþíanón, dódín, fenasakín, flúómetúrón, flútríafól, hexýþíasox, hýmexasól, indólýlsmjörsýru, ísoxaben, brennisteinskalk, metaldehýð, paklóbútrasól, pensýkúrón, sintófen, táflúvalínat og tebúfenósíð
Durchführungsverordnung (EU) 2018/1266 der Kommission vom 20. September 2018 zur Änderung der Durchführungsverordnung (EU) Nr. 540/2011 hinsichtlich der Verlängerung der Genehmigungszeiträume für die Wirkstoffe 1-Decanol, 6-Benzyladenin, Aluminiumsulfat, Azadirachtin, Bupirimat, Carboxin, Clethodim, Cycloxydim, Dazomet, Diclofop, Dithianon, Dodin, Fenazaquin, Fluometuron, Flutriafol, Hexythiazox, Hymexazol, Indolyl-Buttersäure, Isoxaben, Schwefelkalk, Metaldehyd, Paclobutrazol, Pencycuron, Sintofen, Tau-Fluvalinat und Tebufenozid
Kommisjonens gjennomføringsforordning (EU) 2018/1266 av 20. september 2018 om endring av gjennomføringsforordning (EU) nr. 540/2011 med hensyn til forlengelse av godkjenningsperioden for de aktive stoffene 1-dekanol, 6-benzyladenin, aluminiumsulfat, azadiraktin, bupirimat, karboksin, kletodim, sykloksydim, dazomet, diklofop, ditianon, dodin, fenazakin, fluometuron, flutriafol, heksytiazoks, hymeksazol, indolylsmørsyre, isoksaben, svovelpolysulfid, metaldehyd, paklobutrazol, pencykuron, sintofen, tau-fluvalinat og tebufenozid
History
01.06.2019
Adopted JCD confirmed entry into force date
01.06.2019
Compliance date in the EEA
08.05.2019
Adoption of Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement
20.02.2019
Draft Joint Commitee Decision (JCD) incorporating the act into the EEA Agreement sent to Commission
20.09.2018
Adoption date in the EU
11.10.2018
Compliance date in the EU
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.